Abstract
Patulous Eustachian Tube (PET) is a rare otologic disorder, which is caused by abnormal patency of the Eustachian tube. Rapid weight loss is a recognized predisposing factor for PET potentially because of the reduction in peritubal adipose tissue that contributes to normal tubal closure. Although there is increasing awareness of this association, the best treatment of PET is still debated with several conservative, medical and surgical operations reported in the literature. This narrative review summarizes the available evidence regarding conservative, medical, minimally invasive, and surgical management of PET, with particular consideration of PET associated with rapid weight loss. Relevant literature was identified through searches of PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library, with attention to studies using standardized diagnostic criteria and outcome measures. Conservative approaches, including hydration, nasal saline instillation, and behavioral modifications such as cessation of habitual sniffing, have been associated with symptomatic improvement and considered as initial options because of their accessibility and low procedural burden. Medical therapies, such as topical irritants, estrogen-based preparations, and mucosal-thickening agents, may provide temporary symptom relief, although their long-term effects require further evaluation. Among interventional strategies, silicone (Kobayashi) plug insertion has demonstrated encouraging symptom improvement and reductions in symptom scores in selected patients with refractory PET. Minimally invasive techniques, including autologous fat injection, cartilage augmentation, and soft tissue bulking procedures, have also demonstrated encouraging outcomes. Trans-tympanic interventions, including ventilation-tube insertion and catheter-based techniques, provided additional options with variable reported outcomes. Management of PET remains heterogeneous and largely individualized. Conservative and medical therapies are considered reasonable first-line options, while surgical and minimally invasive approaches may be considered for selected patients with persistent symptoms.
1. Introduction
Patulous Eustachian tube (PET) is a rare but clinically important otologic condition characterized by persistent or intermittent abnormal patency of the Eustachian tube [1,2]. The Eustachian tube is normally closed at rest and opens temporarily during swallowing or yawning to equalize middle-ear pressure and facilitate mucociliary clearance [3]. In PET, failure of normal tubal closure results in abnormal communication between the nasopharynx and the middle ear, causing a variety of unpleasant auditory symptoms [4,5]. Patients commonly experience autophony, aural fullness, respiration-synchronous movement of the tympanic membrane, and distortion of their own voice or breathing sounds [6]. These symptoms can significantly impair daily functioning and quality of life, particularly when they are persistent or severe [6].
Although PET may be idiopathic, several secondary etiologies and predisposing conditions have been identified [1,4]. Rapid weight loss is among the recognized predisposing factors for PET [1,7,8]. Significant weight loss may result from bariatric surgery, severe caloric restriction, chronic systemic disease, or pharmacologic weight-loss interventions [1,2,7,8,9]. More recently, PET has also been reported following weight loss associated with glucagon-like peptide-1 receptor agonists [9]. Reports following bariatric surgery and pharmacologically induced weight loss have increased clinical awareness of PET as a possible complication in susceptible individuals [2,9].
The proposed pathophysiological relationship between rapid weight loss and PET is primarily attributed to a reduction in the peritubal adipose tissue surrounding the cartilaginous portion of the Eustachian tube [1,7,8]. This tissue, including the Ostmann fat pad, provides structural support that contributes to passive tubal closure at rest [1]. Rapid or substantial weight loss may reduce this supportive tissue, weaken the normal closure mechanism, and predispose the Eustachian tube to remain abnormally patent [2,7,8]. Other possible contributory factors include changes in mucosal elasticity, surrounding muscular function, and individual anatomical susceptibility [1,4]. However, these mechanisms remain proposed explanations and may not apply equally to all patients with weight loss-associated PET.
Although the association between PET and rapid weight loss is increasingly recognized, the optimal management strategy remains uncertain [10,11,12,13]. The literature describes a range of therapeutic interventions, extending from conservative measures to medical and procedural treatments. Conservative approaches include positional maneuvers, such as adopting a supine or head-down position, which may provide temporary symptom relief by increasing venous congestion around the Eustachian tube, as well as adequate hydration and attempts at weight stabilization or regain when clinically appropriate [10]. Nonprocedural medical treatments include topical nasal preparations, mucosal irritants, and mucosal-thickening agents [10,11]. Minimally invasive procedural treatments include injectable fillers, autologous fat injection, and cartilage or hyaluronic acid augmentation [10,11,14]. Additional interventions for refractory PET include silicone plug insertion, tympanostomy or ventilation tube placement, trans-tympanic procedures, and tympanic membrane mass loading or paper patching [10,11,12,13]. The bulk of the available evidence, however, is in the form of small case series or singular case reports, and there is a great deal of variation in the selection of patients, diagnostic criteria, and the reporting of outcomes. Given the increasing clinical recognition of PET following rapid weight loss and the absence of specific therapeutic guidelines, a comprehensive analysis of the available treatment options is warranted. This narrative review aims to summarize contemporary therapeutic strategies for PET, separately examine the limited evidence concerning PET associated with rapid weight loss, and identify methodological and clinical evidence gaps that should guide future research.
2. Materials and Methods
2.1. Study Design and Review Approach
This narrative review was carried out to summarize and critically examine the available evidence on therapeutic approaches for patulous Eustachian tube (PET). The purpose of the review was to identify and synthesize published literature regarding conservative, medical, minimally invasive, and surgical management strategies for PET. The general methodology was aimed at synthesizing the existing clinical evidence, evaluating reported treatment outcomes, and highlighting methodological limitations related to study design, diagnostic criteria, outcome definitions, and follow-up.
2.2. Search Strategy and Data Sources
A structured literature search was conducted using PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library. The search strategy involved relevant keywords and medical subject headings related to PET, its management, and associated etiologies. Search terms included “patulous Eustachian tube,” “tuba aperta,” “treatment,” “management,” “conservative treatment,” “silicone plug,” “Kobayashi plug,” “augmentation,” “bulking agent,” “tympanostomy,” “rapid weight loss,” “weight reduction,” “bariatric surgery,” “anorexia,” “cachexia,” and “GLP-1 receptor agonist.” No language or publication-date restrictions were applied. The reference lists of relevant publications were also examined to identify additional clinically relevant studies. The search was last updated on 6 May 2026.
2.3. Eligibility Criteria
Studies were considered eligible when they provided clinically relevant information concerning the diagnosis or management of PET. Eligible primary evidence included clinical trials, prospective and retrospective cohort studies, observational studies, case series, and relevant case reports reporting therapeutic interventions and patient outcomes. Systematic and narrative reviews were also considered to provide context regarding the overall evidence base and previously reported treatment approaches.
2.4. Diagnostic Considerations
Particular attention was given to studies using standardized diagnostic criteria, including the Japan Otological Society diagnostic criteria, validated patient-reported outcome measures such as the Patulous Eustachian Tube Handicap Inventory-10 (PHI-10), or objective supportive assessments such as respiration-synchronous tympanometry, sonotubometry, and tubo-tympano-aerodynamic graphy. Other clinically relevant diagnostic approaches, including dynamic otoscopic examination and audiological assessment, were recorded when reported. Because diagnostic practices varied substantially among studies, the diagnostic approach used in each study was considered when interpreting its findings.
2.5. Exclusion Criteria
Publications were excluded from the treatment summary if they lacked sufficient clinically relevant information concerning PET diagnosis, therapeutic intervention, or patient outcomes. Conference abstracts, editorials, and publications limited to anatomical or pathophysiological descriptions without relevant clinical management information were also excluded. The reference lists of included articles were screened to identify additional relevant studies not captured in the initial database search.
2.6. Data Extraction and Classification of Interventions
The information extracted from the eligible studies included the study design, sample characteristics, PET etiology, reported association with rapid weight loss, diagnostic measures used to confirm PET, number of patients and treated ears, type of therapeutic intervention, duration of follow-up, outcome measures, definition of treatment success or improvement, principal findings, recurrence, and reported adverse events. Patient and ear counts were recorded separately when both were provided, and outcomes were reported using the original study denominator. For presentation, management strategies were grouped into three broad categories: conservative and medical management, minimally invasive interventions, and surgical interventions. Conservative and medical management included behavioral modification, nasal saline instillation, and other nonprocedural therapies. Minimally invasive interventions included injectable augmentation or bulking procedures and selected tympanic membrane or trans-tympanic interventions. Surgical interventions included Eustachian tube silicone plug insertion, cartilage myringoplasty, and other operative augmentation or plugging procedures. Studies evaluating interventions from more than one category were assigned according to their principal intervention or study objective. This classification was used to organize the evidence and was not intended to imply comparative effectiveness between treatment categories.
2.7. Data Synthesis and Quality Assessment
The narrative synthesis of the findings of the included studies was conducted. Descriptively summarized outcomes included reported outcomes (symptom improvement), recurrence, the long-term effects of treatment, and complications associated with the procedure. Special attention was given to the studies that examined the use of PET during rapid weight loss and the studies that relied on objective or validated outcome measures to determine the response to treatment. A formal risk-of-bias tool was not used because the review was narrative; the quality of the methodology of the included studies was addressed by looking at aspects like study design, sample size, standardization of diagnostic and strength of reported results.
3. Results
3.1. Summary of Incorporated Studies
Several clinical and observational studies and systematic reviews were found that assessed the therapeutic approaches to the treatment of patulous Eustachian tube (PET) [10,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. These included prospective studies [14,15,19], retrospective studies [16,17,18,20,22,25], observational studies [21,23,24], and systematic reviews [12,13], with sample sizes ranging from 13 patients [25] to more than 900 reported cases [12]. The investigated interventions included conservative, minimally invasive, and surgical approaches, such as silicone plug insertion, autologous fat injection, cartilage augmentation, ventilation tube insertion, and different endoscopic procedures.
Outcome assessment varied across the studies. Some recent studies used standardized or objective measures, including the Patulous Eustachian Tube Handicap Inventory-10 (PHI-10), sonotubometry, and tubo-tympano-aerodynamic graphy, whereas earlier studies relied primarily on patient-reported symptom improvement or satisfaction (Table 1, Table 2 and Table 3). Because the included studies used different definitions of treatment response, complete symptom resolution, partial improvement, patient satisfaction, cessation of habitual sniffing, reductions in symptom scores, and changes in objective test findings were treated as distinct outcomes rather than interchangeable definitions of treatment success.
Table 1.
Conservative and Medical Management of Patulous Eustachian Tube.
Table 2.
Minimally Invasive Interventions for Patulous Eustachian Tube.
Table 3.
Surgical Interventions for Patulous Eustachian Tube.
3.2. Systematic Review Evidence
Two systematic reviews provided detailed reviews of PET surgical interventions [12,13]. Ikeda et al., in a large systematic review of 914 reported cases, found that several surgical procedures had been described for the treatment of PET [12]. Eustachian tube plug surgery was associated with relatively consistent symptom improvement across several included studies. However, heterogeneity in patient selection, diagnostic criteria, outcome definitions, and follow-up prevented conclusions regarding its comparative superiority. The review also reported procedure-related adverse events that should be considered individually rather than collectively characterized as minor. Similarly, Mousa et al. examined the outcomes of 510 surgically treated ears with PET [13]. Complete symptom relief ranged from 7% to 77%, while partial improvement ranged from 7% to 86%. Nonresponse ranged from 0% to 41%, with results varying according to treatment technique and patient population. No included study reported overall worsening of PET symptoms after surgery.
3.3. Silicone Plug (Kobayashi Plug) Interventions
One of the commonly reported surgical treatments was silicone plug insertion, also known as the Kobayashi plug technique. Ikeda et al. conducted a prospective multicenter study involving 30 patients who underwent Kobayashi plug insertion [15]. The mean PHI-10 score decreased significantly from 34.4 ± 4.2 at baseline to 6.4 ± 9.0 and 5.7 ± 8.6 at 3 and 6 months after surgery, respectively. The proportion meeting the study-defined treatment-response criterion was 82.1%. Middle ear effusion (17.2%), tympanic membrane perforation (13.8%), and one case of tinnitus were reported. Although no life-threatening adverse events were reported, these otologic complications were clinically relevant.
Shibasaki et al. evaluated 83 patients who underwent Kobayashi plug surgery [16]. The median PHI-10 score decreased from 33 preoperatively to 14, 16, 16, and 20 at 1, 3, 6, and 12 months after surgery, respectively. Scores remained significantly lower than the preoperative value at every follow-up point, although the increase from 14 at 1 month to 20 at 12 months suggests partial attenuation of the initial improvement. At the corresponding follow-up intervals, the proportions meeting the study-defined treatment-response criterion were 74.0%, 67.1%, 65.0%, and 65.2%. The reported complications included otitis media with effusion (12.5%) and residual tympanic membrane perforation (5.0%). Ventilation tube placement was required in 10 patients (12.1%), and eight patients required revision surgery (9.6%). Four plugs were removed during follow-up.
Kikuchi et al. evaluated Kobayashi plug insertion in 191 patients involving 252 ears in a larger retrospective cohort study [17]. Approximately 83% of treated ears met the study-defined treatment-response criterion. Reported adverse events included persistent otorrhea (1.2%), tympanic membrane perforation (19.4%), middle ear effusion (14.7%), and ventilation tube placement (9.1%).
Kusano et al. conducted a retrospective study involving 60 patients and 68 ears treated with Kobayashi plug surgery [22]. The study-defined treatment-response criterion was met in 76.5% of treated ears, and postoperative tympanic membrane findings were normal in 60.3% of treated ears. Eustachian tube function was assessed objectively using sonotubometry. Abnormal postoperative tympanic membrane findings occurred in 39.7% (27/68 ears), including tympanic membrane perforation in 12 ears, ventilation-tube placement in six ears, plug protrusion in five ears, slight tympanic membrane retraction in two ears, middle-ear effusion in one ear, and subsequent myringoplasty in one ear.
More recently, Yamaguchi et al. evaluated transcanal endoscopic Eustachian tube plug insertion in 13 patients involving 19 ears [25]. The mean PHI-10 score decreased from 26.2 before surgery to 7.5 after surgery. Sonotubometry sound-pressure levels also improved significantly after surgery, and 16 of 19 treated ears (84.2%) met the study-defined treatment-response criterion. One treated ear developed otitis media with effusion, which resolved spontaneously without additional treatment.
3.4. Augmentation Techniques and Injectable Techniques
Several studies examined minimally invasive augmentation procedures intended to narrow the patulous Eustachian tube lumen and improve closure at rest.
Chen et al. evaluated autologous fat injection in 28 patients with PET, and improvement in visual analogue scale (VAS) symptom scores was reported in 92.9% of patients [14]. No postoperative complications were reported by the authors in this cohort.
Another bulking strategy is endoscopic cartilage injection. Oh et al. reported outcomes for 25 patients (33 ears) who received endoscopic cartilage injection, and study-defined symptomatic improvement was reported in 69.7% of treated ears [20]. Transient otitis media was reported in approximately 3% of treated ears.
Schröder et al. evaluated transnasal endoscopic injection of a soft tissue bulking agent in 20 patients [24]. Approximately 66.7% of patients reported satisfaction with the procedure, while 20% reported no improvement. No procedure-related complications were reported by the authors. Satisfaction was considered separately from complete or partial symptom resolution.
Boullaud et al. evaluated several surgical and augmentation procedures in 19 patients involving 30 ears, including hyaluronic acid injection, autologous fat injection, cartilage grafting, hydroxyapatite injection, and endoscopic shim insertion [21]. Postoperative quality of life was assessed using the Glasgow Benefit Inventory. Complete symptom relief was reported by 53% of patients, while 77% reported improvement in quality of life. These findings represent two different outcomes: complete symptom relief and improvement in quality of life. However, recurrence was relatively frequent, with an estimated 3-year recurrence risk of 75%. Transient serous otitis media was reported in 13.3% of patients.
3.5. Trans-Tympanic Procedures
Several studies have evaluated interventions performed through the tympanic membrane. In a study by Oh et al. trans-tympanic catheter insertion was performed in 29 patients (36 ears), with 82.4% of treated ears meeting the study-defined treatment-response criterion based on improvement in symptom scores, including autophony, aural fullness, and respiration-related tympanic membrane movement. These symptoms were assessed using a subjective grading scale to evaluate treatment response [19]. The complications were failed insertion of the catheter (2.7%), ventilation tube insertion (5.6%), and a single case of mastoiditis after ventilation tube extrusion.
Endo et al. evaluated ventilation tube insertion with trans-tympanic silicone plug placement in 31 patients (44 ears) [23]. Study-defined treatment responses were reported in 72.7% of ears treated with silicone plugs and 90.9% of ears treated with ventilation tubes. Tubo-tympano-aerodynamic graphy was used as an objective assessment. Reported adverse events following silicone plug insertion included tympanic membrane perforation in 9.1% (3/33 ears) and middle-ear effusion in 6.1% (2/33 ears). Symptom exacerbation occurred in one ventilation-tube-treated ear.
3.6. Conservative and Medical Management
In addition to the surgical and minimally invasive approaches, several studies have specifically evaluated conservative and medical management strategies for PET, highlighting their role as initial or adjunctive therapies. Conservative measures, particularly hydration, lifestyle modification, and nasal saline instillation, were emphasized in narrative and literature reviews as initial approaches in a general PET population [10,26]. Oshima et al. demonstrated that self-instillation of physiological saline resulted in complete or partial symptom improvement in more than 60% of patients, indicating its practical clinical utility [27].
Similarly, Ikeda et al. reported that behavioral modification, including cessation of habitual sniffing combined with saline instillation, resulted in cessation of sniffing in 65.7% of patients [28]. This finding supports the importance of behavioral modification in addressing contributing habits in PET management.
Medical therapies, including topical irritants, estrogen-based drops, and mucosal thickening agents, have also been explored, with studies suggesting that these interventions may provide temporary symptomatic relief by inducing mucosal edema and reducing Eustachian tube patency, although evidence supporting sustained effectiveness remains limited [10]. Comparative evidence from Kim S et al. further demonstrated that nasal saline irrigation with or without ipratropium bromide was less effective than paper patching but still contributed to partial symptom control in some patients [30]. Wu et al. evaluated 124 patients with PET and specifically examined the influence of rapid weight loss on treatment outcomes [29]. Overall symptom resolution was reported in 39.5% of patients, with rapid weight loss associated with greater odds of symptom improvement. Although this finding is directly relevant to rapid weight loss-associated PET, it should be regarded as an encouraging preliminary observation, and additional subgroup-specific studies are needed to clarify treatment response and guide treatment selection.
4. Discussion
The current narrative review summarized the available evidence on therapeutic approaches to the management of patulous Eustachian tube. PET treatment has been investigated using a wide range of interventions, from conservative and minimally invasive approaches to surgical procedures. In the reviewed literature, silicone plug insertion, autologous fat injection, cartilage augmentation, and trans-tympanic procedures were associated with favorable changes. These findings are consistent with the general literature indicating that PET management remains heterogeneous and largely individualized because of the absence of standardized treatment regimens and high-quality comparative studies [26,27,28,29,30,31,32,33,34].
4.1. Pathophysiological and Clinical Implications
The pathophysiology of PET is believed to be the presence of abnormal patency of the cartilaginous Eustachian tube, which causes improper transmission of nasopharyngeal sound and pressure to the middle ear [1]. Loss of peritubal adipose tissue has been proposed as a contributory mechanism in patients experiencing rapid weight loss because this tissue normally supports passive closure of the Eustachian tube [1,7,8]. Reduction in the Ostmann fat pad and other surrounding soft tissues may therefore predispose susceptible individuals to persistent tubal patency. However, this remains a proposed mechanism and may not explain PET development in every patient with substantial weight loss. Clinical studies have reported PET symptoms following rapid weight reduction, including after bariatric surgery, but the available evidence does not establish its prevalence across all patients who experience substantial weight loss [2,7,8,9,35].
4.2. Rapid Weight Loss-Associated PET
Rapid weight loss-associated PET represents a clinically recognizable subgroup for which treatment evidence remains preliminary. In a bariatric-surgery cohort, Muñoz et al. identified PET in 21.28% of 141 evaluated patients and found that patients with PET experienced greater and more rapid weight loss than those without PET [8]. Other bariatric studies reported symptoms or Eustachian tube functional changes consistent with PET following substantial weight reduction; however, differences in diagnostic methods limit direct comparison of prevalence estimates [7,35]. More recently, a seven-patient case series described PET following an 8.2–18.7% reduction in body weight during GLP-1 receptor agonist therapy. One patient improved with conservative management, whereas six underwent Eustachian tube bulking injections; these findings provide preliminary clinical information regarding management in this emerging subgroup [9]. A separate post-bariatric case report described temporary improvement followed by recurrence within six months after combined balloon dilation and autologous fat injection [2]. Wu et al. provided the most directly relevant outcome analysis: among 124 patients with PET, 39.5% achieved symptom resolution. Patients with rapid weight loss had an estimated greater likelihood of symptom improvement than those with non-rapid weight loss (OR = 4.8), although this estimate did not reach conventional statistical significance (p = 0.053) [29]. Collectively, these findings suggest that weight-loss history may influence clinical presentation and prognosis, but they do not identify a preferred treatment for this subgroup. Initial management may include adequate hydration, weight stabilization or cautious regain when medically appropriate, and avoidance of unnecessary additional weight loss, followed by individualized procedural treatment for persistent, function-limiting symptoms [10,26]. Future prospective studies should report the cause, magnitude, and rate of weight loss and provide treatment outcomes stratified by weight-loss status.
4.3. Standardized Diagnostic and Outcome Measures Role
A notable finding in the current literature review is the growing use of conventional instruments in PET diagnosis and outcome measurement. Traditionally, PET diagnosis was based mainly on clinical findings, i.e., autophony, aural fullness, and movement of the tympanic membrane in accordance with the breathing [6]. However, the use of subjective clinical assessment only can lead to diagnostic ambiguity and inconsistent reporting of treatment outcomes [6]. Recent literature has emphasized standardized diagnostic criteria and validated symptom scales, including the Patulous Eustachian Tube Handicap Inventory-10 (PHI-10) and the Japan Otological Society diagnostic criteria for PET. The PHI-10 provides a quantitative assessment of symptom severity and can be used to monitor treatment response [6,36]. The Japan Otological Society criteria provide a standardized diagnostic framework by integrating characteristic symptoms with objective or supportive findings, including observable tympanic membrane movement with respiration and physiological testing [37]. Objective modalities such as sonotubometry, respiration-synchronous tympanometry, and tubo-tympano-aerodynamic graphy may also be used as supportive assessments to demonstrate abnormal Eustachian tube patency and improve diagnostic consistency [6,37,38].
4.4. Conservative and Medical Management Approaches
Conservative and medical interventions remain initial options in PET management because of their accessibility and comparatively low procedural burden. Conservative strategies such as adequate hydration, weight stabilization, positional adjustments, and nasal saline instillation have been widely reported to provide symptomatic relief, with some studies demonstrating improvement in a substantial proportion of patients [10,26,27]. Similarly, Ikeda et al. reported that behavioral modification, including cessation of habitual sniffing combined with saline instillation, resulted in cessation of sniffing in 65.7% of patients [28]. This finding supports the importance of behavioral modification in addressing contributing habits in PET management.
Medical therapies aim to reduce Eustachian tube patency by inducing mucosal edema or altering local physiology. These include topical irritants, estrogen-containing nasal drops, and mucosal-thickening agents, which may provide temporary symptomatic relief [10]. However, the benefits of these treatments are often transient, and their long-term efficacy remains uncertain. The available evidence does not establish that conservative and medical approaches are generally less effective than surgical interventions because the studies differ substantially in patient selection, treatment indications, outcome definitions, and follow-up. Nevertheless, conservative and medical therapies remain important because of their accessibility and comparatively low procedural burden, and they are commonly used as first-line or adjunctive therapies before procedural intervention [10,26].
4.5. Silicone Plug Surgery Reported Outcomes
Among the reported surgical strategies, silicone plug insertion has demonstrated relatively consistent symptom improvement in several cohorts of patients with refractory PET [12,15,16,17,18,22,25]. The principle of this method involves mechanically narrowing or blocking the abnormally patent Eustachian tube lumen, thereby reducing excessive transmission of nasopharyngeal sound and pressure to the middle ear [39,40]. Reported outcomes suggest that silicone plug insertion may provide symptomatic benefit in selected patients with persistent symptoms that do not respond adequately to conservative management. Advances in surgical technique and sonotubometry-based plug-size selection may also support procedural planning and individualized treatment.
Reported complications included middle-ear effusion, tympanic membrane perforation, ventilation-tube placement, plug removal, and revision surgery. These clinically important outcomes emphasize the need for appropriate patient selection, preoperative counseling, and structured postoperative follow-up.
4.6. Minimally Invasive and Augmentation Techniques
Another potentially useful treatment option involves augmentation procedures that increase tissue bulk around the cartilaginous Eustachian tube, thereby narrowing the abnormally patent lumen and improving closure at rest [10]. Reported materials include autologous fat [14,21], autologous cartilage [20,21], hyaluronic acid [21], calcium hydroxyapatite [10,21], and synthetic soft tissue bulking agents [24,32]. These procedures are particularly appealing because they may be performed endoscopically and may have a lower procedural burden than more extensive surgery. Clinical studies have reported symptomatic improvement following injectable augmentation. However, the studies were predominantly uncontrolled and used different materials and outcome definitions. Consequently, the relative clinical roles of augmentation procedures and other interventions remain to be clarified through appropriately designed comparative studies. Concerns also remain regarding long-term durability because injected materials may undergo partial resorption, potentially resulting in symptom recurrence.
4.7. Trans-Tympanic and Ventilation Tube Procedures
PET management has also been explored using trans-tympanic methods such as catheter insertion and ventilation tube insertion. The logic of such interventions is to decrease the perception of autophony through changing the acoustics of the middle ear and pressure dynamics [26]. Available studies have reported symptom-score improvement in selected patients, although the outcome measures and follow-up periods differed across studies [19,23].
Ventilation tubes may provide symptomatic relief in some patients and can be considered an adjunctive option within an individualized management strategy. The possibility of symptom recurrence after tube extrusion or removal, together with reported complications such as failed catheter insertion, ventilation-tube placement, and mastoiditis, should be considered during treatment selection and patient counseling [19,23].
4.8. Complications and Safety Concerns
Although life-threatening adverse events were not reported in the reviewed procedural studies, clinically important otologic complications occurred. These included middle ear effusion, transient otitis media, persistent tympanic membrane perforation, otorrhea, mastoiditis, ventilation tube placement, plug removal, and revision surgery [13,14,15,16,17,19,20,21,22,23,24,25]. Some studies also reported substantial recurrence or the need for additional procedures [21]. These findings emphasize the importance of reporting procedure-specific adverse events, counseling patients appropriately, and using sufficiently long follow-up periods when assessing treatment safety and durability.
4.9. Limitation of the Existing Body of Evidence
Although favorable outcomes have been reported for several interventions, the existing evidence base remains limited. Many studies are small case series or retrospective cohorts that are susceptible to selection bias and have limited generalizability. Moreover, the absence of standardized diagnostic criteria and outcome measures complicates direct comparison between treatment modalities.
Treatment “success” was not defined consistently and variably represented complete symptom resolution, partial improvement, patient satisfaction, behavioral change, or reduction in a symptom score. Some studies reported outcomes per patient, whereas others reported outcomes per treated ear. These denominators should not be considered interchangeable. Although recent studies increasingly use measures such as the PHI-10 and sonotubometry, these assessments have not been applied uniformly. Most studies also failed to report PET etiology or provide treatment outcomes stratified according to rapid weight-loss status.
4.10. Future Research Implications
The next step in future studies should be the creation of prospective multicenter studies and standardized registries to enhance the quality of evidence in PET management. The use of valid diagnostic criteria and objective outcome measures such as PHI-10 scoring, Japan Otological Society (JOS) diagnostic criteria for patulous Eustachian tube and functional Eustachian tube testing will be necessary in order to allow meaningful comparisons among treatment modalities. Future studies should clearly report PET etiology, diagnostic criteria, numbers of patients and treated ears, definitions of treatment success, duration of follow-up, recurrence, and procedure-specific adverse events. Outcomes should also be stratified for patients with PET associated with bariatric surgery, GLP-1 receptor agonist use, and other causes of rapid weight loss. Comparative studies will help clarify the relative clinical role of each intervention and identify the most appropriate treatment for different patient groups. New minimally invasive procedures, including biodegradable plugs and endoscopic fillers, should also be evaluated with sufficiently long follow-up to determine their durability and safety.
5. Conclusions
In conclusion, the management of PET encompasses a wide range of therapeutic strategies, including conservative, medical, minimally invasive, and surgical interventions. Conservative and medical approaches are considered first-line options due to their accessibility and comparatively low procedural burden, although evidence regarding their long-term effectiveness remains limited. Among interventional options, silicone plug insertion has demonstrated relatively consistent symptomatic improvement in selected patients with refractory PET. Minimally invasive augmentation techniques may also provide symptomatic benefit in selected patients. Current evidence does not establish the comparative superiority of any single intervention for PET. Treatment selection therefore remains individualized according to symptom severity, diagnostic findings, patient characteristics, and preferences. Considerable heterogeneity persists in study design, PET etiology, patient selection, diagnostic criteria, follow-up duration, outcome definitions, and outcome reporting. Furthermore, most treatment studies involved general or mixed-etiology PET populations and did not report outcomes according to weight-loss status.
Author Contributions
Conceptualization, L.A., A.A. and E.B.; methodology, L.A., E.A., M.A. and S.A.; formal analysis, L.A., E.A., M.A. and S.A.; investigation, L.A., E.A., M.A. and S.A.; resources, L.A., E.A., M.A. and S.A.; data curation, L.A., E.A., M.A. and S.A.; writing—original draft preparation, L.A. and E.A.; writing—review and editing, M.A. and S.A.; visualization, L.A., E.A., M.A. and S.A.; supervision, M.A., S.A., A.A. and E.B.; project administration, A.A. and E.B. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
No new data were created or analyzed in this study. Data sharing is not applicable to this article.
Conflicts of Interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
- Bance, M.; Tysome, J.R.; Smith, M.E. Patulous Eustachian tube (PET), a practical overview. World J. Otorhinolaryngol.-Head Neck Surg. 2019, 5, 137–142. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Arkoubi, A.Y. Management of patulous Eustachian tube dysfunction following bariatric surgery: A case report. Front. Surg. 2025, 12, 1614291. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bal, R.; Deshmukh, P. Management of Eustachian Tube Dysfunction: A Review. Cureus 2022, 14, e31432. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R. Diagnosis and treatment of patulous eustachian tube. Auris Nasus Larynx 2024, 51, 947–955. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kim, H.Y. Eustachian tube dysfunction in Hearing loss: Mechanistic Pathways to Targeted Interventions. Biomedicines 2025, 13, 2686. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kawamura, Y.; Ikeda, R.; Kikuchi, T.; Miyazaki, H.; Kawase, T.; Katori, Y.; Kobayashi, T. The characteristic of patulous eustachian tube patients diagnosed by the JOS diagnostic criteria. PLoS ONE 2019, 14, e0226908. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Abreu, C.; Silva, M.; Weber, R.; Pignatari, S.; Stamm, A.; Pascoto, G. The impact of acute loss of weight on eustachian tube function. Int. Arch. Otorhinolaryngol. 2014, 18, 376–379. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Muñoz, D.; Aedo, C.; Der, C. Patulous eustachian tube in bariatric surgery patients. Otolaryngol. Head Neck Surg. 2010, 143, 521–524. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sudhoff, H. First report on a case series of Patulous Eustachian tube following GLP-1 receptor agonist-induced weight loss. Eur. Arch. Oto-Rhino-Laryngol. 2025, 282, 6533–6538. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Koltsidopoulos, P.; Skoulakis, C. Current treatment options for Patulous Eustachian Tube: A Review of the literature. Ear Nose Throat J. 2020, 145561320932807. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Luu, K.; Remillard, A.; Fandino, M.; Saxby, A.; Westerberg, B.D. Treatment effectiveness for symptoms of patulous eustachian tube. Otol. Neurotol. 2015, 36, 1593–1600. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Hidaka, H.; Kikuchi, T.; Ohta, N.; Kawase, T.; Katori, Y.; Kobayashi, T. Systematic review of surgical outcomes following repair of patulous eustachian tube. Otol. Neurotol. 2020, 41, 1012–1020. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mousa, Z.; Faber, C.; Rosenberg, T. Surgical treatment of patulous Eustachian tube-a systematic review. Dan. Med. J. 2020, 67, A02200068. Available online: https://pubmed.ncbi.nlm.nih.gov/33046204/ (accessed on 15 January 2026). [PubMed]
- Chen, J.; Xiong, H.; Chen, Y.; Yang, H. Autologous fat injection for the treatment of patulous eustachian tube. J. Int. Adv. Otol. 2023, 19, 311–317. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Oshima, T.; Mizuta, K.; Arai, M.; Endo, S.; Hirai, R.; Ikeda, K.; Kadota, S.; Otsuka, Y.; Yamaguchi, T.; et al. Efficacy of a silicone plug for patulous eustachian tube: A prospective, multicenter case series. Laryngoscope 2019, 130, 1304–1309. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shibasaki, T.; Koike, N.; Shindo, H.; Hirai, R.; Oshima, T. Postoperative course of Eustachian tube plug surgery with Kobayashi plug. Auris Nasus Larynx 2025, 52, 116–121. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kikuchi, T.; Ikeda, R.; Oshima, H.; Takata, I.; Kawase, T.; Oshima, T.; Katori, Y.; Kobayashi, T. Effectiveness of Kobayashi plug for 252 ears with chronic patulous Eustachian tube. Acta Oto-Laryngol. 2016, 137, 253–258. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Kikuchi, T.; Kawamura, Y.; Miyaaki, H.; Kawase, T.; Katori, Y.; Kobayashi, T. Plug size selection protocol for the treatment of intractable patulous Eustachian tube with Kobayashi Plug. Acta Oto-Laryngol. 2019, 139, 849–853. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Oh, S.J.; Lee, I.W.; Goh, E.K.; Kong, S.K. Trans-tympanic catheter insertion for treatment of patulous eustachian tube. Am. J. Otolaryngol. 2015, 36, 748–752. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Oh, S.J.; Lee, I.W.; Goh, E.K.; Kong, S.K. Endoscopic autologous cartilage injection for the patulous eustachian tube. Am. J. Otolaryngol. 2015, 37, 78–82. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Boullaud, L.; D’aNdrea, G.; Fabre, R.; AlShukry, A.; Castillo, L.; Guevara, N.; Vandersteen, C. Mid-term evaluation of the surgical management of patulous Eustachian tube dysfunction: A STROBE observational study. Eur. Arch. Oto-Rhino-Laryngol. 2023, 281, 2883–2891. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kusano, Y.; Ikeda, R.; Kawamura, Y.; Oshima, H.; Nomura, Y.; Kikuchi, T.; Kawase, T.; Katori, Y.; Kobayashi, T. Tympanic membrane findings and Eustachian tube function after transtympanic plugging for the chronic patulous Eustachian tube. Auris Nasus Larynx 2023, 50, 859–865. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Endo, S.; Mizuta, K.; Takahashi, G.; Nakanishi, H.; Yamatodani, T.; Misawa, K.; Hosokawa, S.; Mineta, H. The effect of ventilation tube insertion or trans-tympanic silicone plug insertion on a patulous Eustachian tube. Acta Oto-Laryngol. 2016, 136, 551–555. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Schröder, S.; Lehmann, M.; Sudhoff, H.H.; Ebmeyer, J. Treatment of the Patulous Eustachian Tube with Soft-Tissue Bulking Agent Injections. Otol. Neurotol. 2014, 36, 448–452. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yamaguchi, W.; Hirabayashi, M.; Kurihara, S.; Takahashi, M.; Fukuda, T.; Yamamoto, K.; Sakurai, Y.; Yamamoto, Y. Clinical outcomes of transcanal endoscopic eustachian tube plug insertion. Otol. Neurotol. 2025, 47, 161–168. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Kikuchi, T.; Oshima, H.; Kobayashi, T. Management of Patulous Eustachian tube. JMA J. 2020, 3, 101–108. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Oshima, T.; Kikuchi, T.; Kawase, T.; Kobayashi, T. Nasal instillation of physiological saline for patulous eustachian tube. Acta Oto-Laryngol. 2010, 130, 550–553. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Oshima, T.; Oshima, H.; Miyazaki, M.; Kikuchi, T.; Kawase, T.; Kobayashi, T. Management of patulous Eustachian tube with habitual sniffing. Otol. Neurotol. 2011, 32, 790–793. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wu, S.S.; Cabrera, C.I.; Kominsky, R.A.; Richardson, C.M.; Semaan, M.; Rodriguez, K.; Otteson, T.; D’ANza, B. Impact of body mass index in patulous Eustachian tube: Does rapid weight loss influence symptom improvement? Am. J. Otolaryngol. 2022, 43, 103581. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kim, S.J.; Shin, S.A.; Lee, H.Y.; Park, Y.H. Paper patching for patulous eustachian tube. Acta Oto-Laryngol. 2019, 139, 122–128. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Si, Y.; Chen, Y.; Li, P.; Jiang, H.; Xu, G.; Li, Z.; Zhang, Z. Eardrum thickening approach for the treatment of patulous Eustachian tube. Eur. Arch. Oto-Rhino-Laryngol. 2016, 273, 3673–3678. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sudhoff, H.; Ay, N.; Todt, I.; Sauzet, O.; Bernal-Sprekelsen, M.; Scholtz, L.U. A novel technique for patulous Eustachian tube augmentation. Eur. Arch. Oto-Rhino-Laryngol. 2020, 278, 2219–2224. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hussein, A.A.; Adams, A.S.; Turner, J.H. Surgical management of Patulous eustachian tube: A systematic review. Laryngoscope 2015, 125, 2193–2198. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Grimmer, J.F.; Poe, D.S. Update on eustachian tube dysfunction and the patulous eustachian tube. Curr. Opin. Otolaryngol. Head Neck Surg. 2005, 13, 277–282. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Albawardi, K.A., Sr.; Alsanad, F.A.; Aldosari, H.S.; Alhelal, S.A.; Alasmari, M.M.; Alsadi, M.A.; Aldohayan, A. The prevalence of hearing symptoms associated with patulous Eustachian tube dysfunction following bariatric surgery at King Khalid University Hospital, Saudi Arabia. Cureus 2023, 15, e43255. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ikeda, R.; Kikuchi, T.; Oshima, H.; Miyazaki, H.; Hidaka, H.; Kawase, T.; Katori, Y.; Kobayashi, T. New scoring system for evaluating patulous Eustachian tube patients. Otol. Neurotol. 2017, 38, 708–713. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kobayashi, T.; Morita, M.; Yoshioka, S.; Mizuta, K.; Ohta, S.; Kikuchi, T.; Hayashi, T.; Kaneko, A.; Yamaguchi, N.; Hashimoto, S.; et al. Diagnostic criteria for Patulous Eustachian Tube: A proposal by the Japan Otological Society. Auris Nasus Larynx 2018, 45, 1–5. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Smith, M.E.; Scoffings, D.J.; Tysome, J.R. Imaging of the Eustachian tube and its function: A systematic review. Neuroradiology 2016, 58, 543–556. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bae, S.H.; Cheon, T.; Kong, S.; Moon, I.S. Optimal Eustachian tube plugging method for patulous Eustachian tube disorder. Clin. Otolaryngol. 2025, 51, 121–126. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sato, T.; Kawase, T.; Yano, H.; Suetake, M.; Kobayashi, T. Trans-tympanic silicone plug insertion for chronic patulous Eustachian tube. Acta Oto-Laryngol. 2005, 125, 1158–1163. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.